Skip to main content

Table 3 Summary characteristics by treatment status among HIV-1 infected participants with viral load ≥ 1000 copies/ml

From: The HIV care continuum and HIV-1 drug resistance among female sex workers: a key population in Guinea-Bissau

  Treatment naivea (n = 53) ART expereriencedb (n = 22) Treatment Naive vs ART experienced
p-value
Age 30 (24–35) 42 (30–46) .002c
HIV-1/2 dual-infected 4 (7.6%) 5 (22.7%) 0.07d
CD4 cells/mm3 584 (373–787) 432 (184–726) .17c
HIV-1 VL copies/ml 25,461 (5649–59,182) 7130 (2707–21,771) .01c
Previous diagnosis 14 (27.5%) 22 (100.0%) NA
Non-mutated virus 48 (90.6%) 11 (50.0%)  
Detectable resistance 5 (9.4%) 11 (50.0%) < .001d
NNRTI only 3 (5.7%) 4 (18.2%) NA
NRTI only 2 (3.8%) 2 (9.1%) NA
NRTI + NNRTI 0 (0.0%) 4 (18.1%) NA
PI minor 0 (0.0%) 1 (4.6%) NA
  1. Data are n (%) or median (IQR)
  2. ART antiretroviral therapy, NNRTI non-nucleoside reverse transcriptase inhibitors, NRTI nucleoside reverse transcriptase inhibitor, NA not applicable, PI protease inhibitors, VL viral load
  3. aIncluding 3 seroincident individuals
  4. bIncluding 3 individuals with previous ART use
  5. cMann–Whitney test U test
  6. dChi Square test